Cornelia Landersdorfer
Cornelia Landersdorfer
Verified email at
Cited by
Cited by
Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis
AA Agyeman, KL Chin, CB Landersdorfer, D Liew, R Ofori-Asenso
Mayo Clinic Proceedings 95 (8), 1621-1631, 2020
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens
AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ...
Clinical infectious diseases 57 (4), 524-531, 2013
Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations
CB Landersdorfer, JB Bulitta, M Kinzig, U Holzgrabe, F Sörgel
Clinical pharmacokinetics 48, 89-124, 2009
Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans
F Sörgel, R Weissenbacher, M Kinzig-Schippers, A Hofmann, M Illauer, ...
Chemotherapy 48 (6), 267-274, 2003
Pharmacokinetics and pharmacodynamics of ‘old’polymyxins: what is new?
PJ Bergen, CB Landersdorfer, J Zhang, M Zhao, HJ Lee, RL Nation, J Li
Diagnostic microbiology and infectious disease 74 (3), 213-223, 2012
Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta, CB Landersdorfer
Expert review of anti-infective therapy 11 (12), 1333-1353, 2013
‘Old’antibiotics for emerging multidrug-resistant bacteria
PJ Bergen, CB Landersdorfer, HJ Lee, J Li, RL Nation
Current opinion in infectious diseases 25 (6), 626-633, 2012
Development of a new pre-and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT
JB Bulitta, A Bingölbali, BS Shin, CB Landersdorfer
The AAPS journal 13, 201-211, 2011
Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers
WA Krueger, J Bulitta, M Kinzig-Schippers, C Landersdorfer, U Holzgrabe, ...
Antimicrobial agents and chemotherapy 49 (5), 1881-1889, 2005
Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus
CB Landersdorfer, WJ Jusko
Clinical pharmacokinetics 47, 417-448, 2008
Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models
CB Landersdorfer, J Wang, V Wirth, K Chen, KS Kaye, BT Tsuji, J Li, ...
Journal of Antimicrobial Chemotherapy 73 (2), 462-468, 2018
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling
JB Bulitta, NS Ly, CB Landersdorfer, NA Wanigaratne, T Velkov, R Yadav, ...
Antimicrobial agents and chemotherapy 59 (4), 2315-2327, 2015
A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections
AA Agyeman, PJ Bergen, GG Rao, RL Nation, CB Landersdorfer
International journal of antimicrobial agents 55 (1), 105833, 2020
Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models
JB Bulitta, CB Landersdorfer
The AAPS journal 13 (2), 212-226, 2011
PK/PD models in antibacterial development
T Velkov, PJ Bergen, J Lora-Tamayo, CB Landersdorfer, J Li
Current opinion in microbiology 16 (5), 573-579, 2013
Colistin: how should it be dosed for the critically ill?
CB Landersdorfer, RL Nation
Seminars in respiratory and critical care medicine 36 (01), 126-135, 2015
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design
CB Landersdorfer, NS Ly, H Xu, BT Tsuji, JB Bulitta
Antimicrobial agents and chemotherapy 57 (5), 2343-2351, 2013
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ...
Journal of Antimicrobial Chemotherapy 68 (3), 674-677, 2013
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
NS Ly, JB Bulitta, GG Rao, CB Landersdorfer, PN Holden, A Forrest, ...
Journal of antimicrobial chemotherapy 70 (5), 1434-1442, 2015
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system
HY Lin, CB Landersdorfer, D London, R Meng, CU Lim, C Lin, S Lin, ...
PLoS computational biology 7 (2), e1001073, 2011
The system can't perform the operation now. Try again later.
Articles 1–20